Atara Biotherapeutics (ATRA) Accounts Payables (2022 - 2025)
Historic Accounts Payables for Atara Biotherapeutics (ATRA) over the last 4 years, with Q3 2025 value amounting to $318000.0.
- Atara Biotherapeutics' Accounts Payables fell 8518.17% to $318000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $318000.0, marking a year-over-year decrease of 8518.17%. This contributed to the annual value of $4.4 million for FY2024, which is 1853.96% up from last year.
- As of Q3 2025, Atara Biotherapeutics' Accounts Payables stood at $318000.0, which was down 8518.17% from $1.8 million recorded in Q2 2025.
- Atara Biotherapeutics' Accounts Payables' 5-year high stood at $12.8 million during Q2 2022, with a 5-year trough of $318000.0 in Q3 2025.
- In the last 4 years, Atara Biotherapeutics' Accounts Payables had a median value of $4.4 million in 2024 and averaged $5.4 million.
- Per our database at Business Quant, Atara Biotherapeutics' Accounts Payables surged by 2694.54% in 2024 and then tumbled by 8518.17% in 2025.
- Quarter analysis of 4 years shows Atara Biotherapeutics' Accounts Payables stood at $6.9 million in 2022, then plummeted by 46.38% to $3.7 million in 2023, then rose by 18.54% to $4.4 million in 2024, then plummeted by 92.72% to $318000.0 in 2025.
- Its Accounts Payables stands at $318000.0 for Q3 2025, versus $1.8 million for Q2 2025 and $1.4 million for Q1 2025.